A comprehensive characterization of the transcriptome in enzalutamide resistance prostate cancer

BACKGROUND: Prostate cancer (PCa) contributes to more than 1.2 million newly diagnosed cases and more than 350,000 deaths each year, making it the second most common malignancy and the fifth leading cause of cancer-related deaths in men worldwide. Treatment of PCa is further complicated by drug resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lili, Peng, Yun, Dong, Shiqiang, Hou, Dingkun, Li, Nan, Li, Hongzheng, Li, Tianyang, Zhang, Zheyu, Wang, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756251/
https://www.ncbi.nlm.nih.gov/pubmed/35071476
http://dx.doi.org/10.21037/atm-21-6191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756251/
https://www.ncbi.nlm.nih.gov/pubmed/35071476
http://dx.doi.org/10.21037/atm-21-6191

Ejemplares similares